Masimo Legal Battle with Apple over Patent
The clash stems from Masimo’s pioneering pulse oximeter technology, which uses light to measure blood oxygen levels. Apple’s Apple Watch Series 6, released in 2020, incorporated similar technology, raising suspicions of patent infringement. Masimo cried foul, alleging Apple had misappropriated their innovations.
Masimo Takes a Stand: David and Goliath in the Valley of Patents
Kiani embarked on a David-and-Goliath legal crusade. Despite warnings about the immense resources of his adversary, he remained undeterred. He saw this as a battle not just for Masimo’s patents, but for the rights of smaller companies in the face of tech giants’ alleged predatory practices.
The fight’s consequences: A costly gamble with high stakes
The financial weight of this fight is undeniable. $100 million is a hefty sum for any company, let alone one with annual profits just 50% larger. This expenditure has undoubtedly impacted Masimo’s operations and future investments.
Yet, Kiani stands firm, his conviction unyielding. He believes that a victory, even a partial one, could set a precedent, forcing Apple to be more respectful of intellectual property and fostering a fairer environment for smaller players in the tech ecosystem. With the $3Trillon worth of apple, some people are of the opinion that Masimo should give us. However, some others praised Masimo for their bravery and consistency.
The legal battle is far from over. Currently, Masimo secured a temporary import ban on some Apple Watch models in December 2023, Apple swiftly appealed, and the ban is currently paused. Both sides continue to fight, awaiting a final verdict.
Kiani’s fight has resonated in the tech community, sparking debates about patent protection, corporate ethics, and the power dynamics in the tech industry. Whatever the legal outcome, Masimo’s David-and-Goliath story has already become a symbol of courage and the fight for a more equitable tech landscape.
You May Like:
